BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 34185315)

  • 1. Online monitoring and control of upstream cell culture process using 1D and 2D-LC with SegFlow interface.
    Chemmalil L; Wasalathanthri DP; Zhang X; Kuang J; Shao C; Barbour R; Bhavsar S; Prabhakar T; Knihtila R; West J; Puri N; McHugh K; Rehmann MS; He Q; Xu J; Borys MC; Ding J; Li Z
    Biotechnol Bioeng; 2021 Sep; 118(9):3593-3603. PubMed ID: 34185315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Online/at-line measurement, analysis and control of product titer and critical product quality attributes (CQAs) during process development.
    Chemmalil L; Prabhakar T; Kuang J; West J; Tan Z; Ehamparanathan V; Song Y; Xu J; Ding J; Li Z
    Biotechnol Bioeng; 2020 Dec; 117(12):3757-3765. PubMed ID: 32776503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Fully Integrated Online Platform For Real Time Monitoring Of Multiple Product Quality Attributes In Biopharmaceutical Processes For Monoclonal Antibody Therapeutics.
    Liu Y; Zhang C; Chen J; Fernandez J; Vellala P; Kulkarni TA; Aguilar I; Ritz D; Lan K; Patel P; Liu A
    J Pharm Sci; 2022 Feb; 111(2):358-367. PubMed ID: 34534574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On-Line Ion Exchange Liquid Chromatography as a Process Analytical Technology for Monoclonal Antibody Characterization in Continuous Bioprocessing.
    Patel BA; Pinto NDS; Gospodarek A; Kilgore B; Goswami K; Napoli WN; Desai J; Heo JH; Panzera D; Pollard D; Richardson D; Brower M; Richardson DD
    Anal Chem; 2017 Nov; 89(21):11357-11365. PubMed ID: 28981255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling the Downstream Processing of Monoclonal Antibodies Reveals Cost Advantages for Continuous Methods for a Broad Range of Manufacturing Scales.
    Hummel J; Pagkaliwangan M; Gjoka X; Davidovits T; Stock R; Ransohoff T; Gantier R; Schofield M
    Biotechnol J; 2019 Feb; 14(2):e1700665. PubMed ID: 29341493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of Fully Integrated Continuous Antibody Processing: Effects on Productivity and COGm.
    Arnold L; Lee K; Rucker-Pezzini J; Lee JH
    Biotechnol J; 2019 Feb; 14(2):e1800061. PubMed ID: 29729129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot-scale demonstration of an end-to-end integrated and continuous biomanufacturing process.
    Coolbaugh MJ; Varner CT; Vetter TA; Davenport EK; Bouchard B; Fiadeiro M; Tugcu N; Walther J; Patil R; Brower K
    Biotechnol Bioeng; 2021 Sep; 118(9):3287-3301. PubMed ID: 33410159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous Monitoring and Comparison of Multiple Product Quality Attributes for Cell Culture Processes at Different Scales Using a LC/MS/MS Based Multi-Attribute Method.
    Liu Y; Fernandez J; Pu Z; Zhang H; Cao L; Aguilar I; Ritz D; Luo R; Read A; Laures A; Lan K; Ubiera A; Smith A; Patel P; Liu A
    J Pharm Sci; 2020 Nov; 109(11):3319-3329. PubMed ID: 32758544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward biotherapeutic product real-time quality monitoring.
    Guerra A; von Stosch M; Glassey J
    Crit Rev Biotechnol; 2019 May; 39(3):289-305. PubMed ID: 30724608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-time monitoring of antibody quality attributes for cell culture production processes in bioreactors via integration of an automated sampling technology with multi-dimensional liquid chromatography mass spectrometry.
    Dahotre S; Dai L; Kjenstad K; Stella C; Camperi J
    J Chromatogr A; 2022 Jun; 1672():463067. PubMed ID: 35462311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated Online-Sampling Multidimensional Liquid Chromatography with Feedback-Control Capability as a Framework for Real-Time Monitoring of mAb Critical Quality Attributes in Multiple Bioreactors.
    Dunn ZD; Bohman P; Quinteros A; Sauerborn B; Milman F; Patel M; Kargupta R; Wu S; Hornshaw M; Barrientos R; Bones J; Tayi VS; Abaroa N; Patel B; Appiah-Amponsah E; Regalado EL
    Anal Chem; 2023 Dec; 95(49):18130-18138. PubMed ID: 38015205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enablers of continuous processing of biotherapeutic products.
    Rathore AS; Zydney AL; Anupa A; Nikita S; Gangwar N
    Trends Biotechnol; 2022 Jul; 40(7):804-815. PubMed ID: 35034769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic assessment of process analytical technologies for biologics.
    Gillespie C; Wasalathanthri DP; Ritz DB; Zhou G; Davis KA; Wucherpfennig T; Hazelwood N
    Biotechnol Bioeng; 2022 Feb; 119(2):423-434. PubMed ID: 34778948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taking the pulse of bioprocesses: at-line and in-line monitoring of mammalian cell cultures.
    Fung Shek C; Betenbaugh M
    Curr Opin Biotechnol; 2021 Oct; 71():191-197. PubMed ID: 34454382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The design basis for the integrated and continuous biomanufacturing framework.
    Coffman J; Bibbo K; Brower M; Forbes R; Guros N; Horowski B; Lu R; Mahajan R; Patil U; Rose S; Shultz J
    Biotechnol Bioeng; 2021 Sep; 118(9):3323-3333. PubMed ID: 33522595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current challenges and recent advances on the path towards continuous biomanufacturing.
    Drobnjakovic M; Hart R; Kulvatunyou BS; Ivezic N; Srinivasan V
    Biotechnol Prog; 2023; 39(6):e3378. PubMed ID: 37493037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. End-to-end continuous bioprocessing: Impact on facility design, cost of goods, and cost of development for monoclonal antibodies.
    Mahal H; Branton H; Farid SS
    Biotechnol Bioeng; 2021 Sep; 118(9):3468-3485. PubMed ID: 33792918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Throughput Optimization of Continuous Biopharmaceutical Manufacturing Facilities.
    Garcia FA; Vandiver MW
    PDA J Pharm Sci Technol; 2017; 71(3):189-205. PubMed ID: 27974629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expediting online liquid chromatography for real-time monitoring of product attributes to advance process analytical technology in downstream processing of biopharmaceuticals.
    Graf T; Naumann L; Bonnington L; Heckel J; Spensberger B; Klein S; Brey C; Nachtigall R; Mroz M; Hogg TV; McHardy C; Martinez A; Braaz R; Leiss M
    J Chromatogr A; 2024 Aug; 1729():465013. PubMed ID: 38824753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated continuous production of recombinant therapeutic proteins.
    Warikoo V; Godawat R; Brower K; Jain S; Cummings D; Simons E; Johnson T; Walther J; Yu M; Wright B; McLarty J; Karey KP; Hwang C; Zhou W; Riske F; Konstantinov K
    Biotechnol Bioeng; 2012 Dec; 109(12):3018-29. PubMed ID: 22729761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.